# A Long-term Study of AK102 in Patients With Hypercholesterolemia

> **NCT04173403** · PHASE2 · COMPLETED · sponsor: **Akeso** · enrollment: 796 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** 450mg AK102
- **DRUG:** 300mg AK102
- **DRUG:** 150mg AK102
- **DRUG:** Statins and/or Ezetimibe

## Key facts

- **NCT ID:** NCT04173403
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2023-02-17
- **Final completion:** 2023-02-17
- **Target enrollment:** 796 (ACTUAL)
- **Last updated:** 2023-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173403, "A Long-term Study of AK102 in Patients With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04173403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*